{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:51:57Z","timestamp":1789692717637,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1245\/s10434-009-0641-z","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T15:41:30Z","timestamp":1249314090000},"page":"2697-2704","source":"Crossref","is-referenced-by-count":195,"title":["Patient and Surgeon Characteristics Associated with Increased Use of Contralateral Prophylactic Mastectomy in Patients with Breast Cancer"],"prefix":"10.1245","volume":"16","author":[{"given":"Amanda K.","family":"Arrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Jarosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Virnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"641_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/bjc.1984.12","volume":"49","author":"TG Hislop","year":"1984","unstructured":"Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast; incidence and risk factors. Br J Cancer. 1984;49:79\u201385.","journal-title":"Br J Cancer"},{"key":"641_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/ejso.1999.0711","volume":"25","author":"J Kollias","year":"1999","unstructured":"Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25:584\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"641_CR3","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738\u201346.","journal-title":"J Clin Oncol"},{"key":"641_CR4","first-page":"904","volume":"106","author":"PP Rosen","year":"1989","unstructured":"Rosen PP, Groshen S, Kinne DW, Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989;106:904\u201310.","journal-title":"Surgery"},{"key":"641_CR5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1993.11.8.1545","volume":"11","author":"EA Healey","year":"1993","unstructured":"Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545\u201352.","journal-title":"J Clin Oncol"},{"key":"641_CR6","doi-asserted-by":"crossref","unstructured":"Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004;18(4):CD002748. Review.","DOI":"10.1002\/14651858.CD002748.pub2"},{"key":"641_CR7","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","volume":"19","author":"SK McDonnell","year":"2001","unstructured":"McDonnell SK, Schaid DJ, Myers JL, et al. Efficacy of contralateral prophylactic mastectomy in patients with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938\u201343.","journal-title":"J Clin Oncol"},{"key":"641_CR8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","volume":"180","author":"EA Peralta","year":"2000","unstructured":"Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180:439\u201345.","journal-title":"Am J Surg"},{"key":"641_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","volume":"93","author":"TC Sprundel van","year":"2005","unstructured":"van Sprundel TC, Schmidt MK, Rookus MA, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 2005;93:287\u201392.","journal-title":"Br J Cancer"},{"key":"641_CR10","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in patients with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23:4275\u201386.","journal-title":"J Clin Oncol"},{"key":"641_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jncimonographs\/lgi039","volume":"35","author":"MB Barton","year":"2005","unstructured":"Barton MB, West CN, Liu IL, et al. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;35:61\u20136.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"641_CR12","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203\u20139.","journal-title":"J Clin Oncol"},{"key":"641_CR13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362\u20137.","journal-title":"J Clin Oncol"},{"key":"641_CR14","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Treatment of early stage breast cancer. JAMA. 1991;265:391\u20135.","DOI":"10.1001\/jama.1991.03460030097037"},{"issue":"Suppl 15S","key":"641_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/jco.2008.26.15_suppl.509","volume":"26","author":"R Katipamula","year":"2008","unstructured":"Katipamula R, Hoskin TL, Boughey JC, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative MRI. J Clin Oncol. 2008;26(Suppl 15S):509.","journal-title":"J Clin Oncol"},{"key":"641_CR16","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1245\/s10434-009-0362-3","volume":"16","author":"ME Sorbero","year":"2009","unstructured":"Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597\u2013605.","journal-title":"Ann Surg Oncol"},{"key":"641_CR17","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328\u201335.","journal-title":"J Clin Oncol"},{"key":"641_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jama.283.5.617","volume":"283","author":"D Schrag","year":"2000","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for patients with breast cancer and BRCA1 or BRCA2 mutations. JAMA.\u00a02000;283:617\u201324.","journal-title":"JAMA"},{"key":"641_CR19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993\u20132000.","journal-title":"Lancet"},{"key":"641_CR20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/cncr.21728","volume":"106","author":"AB Chagpar","year":"2006","unstructured":"Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106:1462\u20136.","journal-title":"Cancer"},{"key":"641_CR21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","volume":"6","author":"LL Montgomery","year":"1999","unstructured":"Montgomery LL, Tran KN, Heelan MC, Van Zee KJ, Massie MJ, Payne DK, Borgen PI. Issues of regret in patients with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546\u201352.","journal-title":"Ann Surg Oncol"},{"key":"641_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jncimonographs\/lgi038","volume":"35","author":"L Nekhlyudov","year":"2005","unstructured":"Nekhlyudov L, Bower M, Herrinton LJ, et al. Patients\u2019 decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;35:55\u201360.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"641_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00005650-199910000-00009","volume":"37","author":"RA Silliman","year":"1999","unstructured":"Silliman RA, Demissie S, Troyan SL. The care of older patients with early-stage breast cancer: what is the role of surgeon gender? Med Care. 1999;37:1057\u201367.","journal-title":"Med Care"},{"key":"641_CR24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/000313480206800419","volume":"68","author":"E Weinberg","year":"2002","unstructured":"Weinberg E, Wood S, Grannen K. The influence of gender of the surgeon on surgical procedure preference for breast cancer. Am Surg. 2002;68:398\u2013400.","journal-title":"Am Surg"},{"key":"641_CR25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/SLA.0b013e3181a38f6f","volume":"249","author":"DL Hershman","year":"2009","unstructured":"Hershman DL, Buono D, Jacobson JS, McBride RB, Tsai WY, Joseph KA, Neugut AI. Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg. 2009;249:828\u201333.","journal-title":"Ann Surg"},{"key":"641_CR26","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.20617","volume":"101","author":"K Goldflam","year":"2004","unstructured":"Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101:1977\u201386.","journal-title":"Cancer"},{"key":"641_CR27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/jnci\/83.18.1278","volume":"83","author":"B Fisher","year":"1991","unstructured":"Fisher B, Redmond C. New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. J Natl Cancer Inst. 1991;83:1278\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"641_CR28","first-page":"117","volume":"11","author":"Stewart HJ for the Scottish Cancer Trials Breast Group","year":"1992","unstructured":"Stewart HJ for the Scottish Cancer Trials Breast Group. The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. J Natl Cancer Inst Monogr. 1992;11:117\u201320.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"641_CR29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/83.18.1299","volume":"83","author":"LE Rutvist","year":"1991","unstructured":"Rutvist LE, Cedermark B, Glas U, et al. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst. 1991;83:1299\u2013306.","journal-title":"J Natl Cancer Inst"},{"key":"641_CR30","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","volume":"359","author":"M Baum","year":"2002","unstructured":"Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T; ATAC Trialists\u2019 Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of post-menopausal patients with early breast cancer: First results of the ATAC randomised trial. Lancet. 2002;359:2131\u20139.","journal-title":"Lancet"},{"key":"641_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01806627","volume":"37","author":"JW Meakin","year":"1996","unstructured":"Meakin JW, Hayward JL, Panzarella T, et al. Ovarian radiation and prednisone following surgery and radiotherapy for carcinoma of the breast. Breast Cancer Res Treat. 1996;37:11\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"641_CR32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351:1451\u201367.","journal-title":"Lancet"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0641-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0641-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:26:56Z","timestamp":1685082416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0641-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]}}}